Matthew Halpert's guest appearances

Matthew Halpert

Cannabis Economy

Be Informed. Be Well. With John Malanca

Power On Your Plate with Haylie Pomroy

David Gordon

Tim McGraw

Grover Norquist

Michael Bronstein

Tulsi Gabbard

John Davis

Tommy Chong

Henry Rollins

Jesse Ventura

Melissa Etheridge

Ethan Nadelmann

Marvin Washington

Ngaio Bealum

Jim Belushi

Keith Stroup

OwlTail

Dr. Matthew Halpert holds a Ph.D from the University of Alabama and holds a faculty position at Baylor College of Medicine in Houston, Texas. Dr. Halpert is the Director of Research &amp; Development at Medterra and is currently responsible for all its product related research and development.  These activities include performing pharmacological studies on CBD’s efficacy, while evaluating the latest peer reviewed publications on CBD. Matthew Halpert and John Malanca discuss his entry into the CBD market and some interesting observation and study results.  John Malanca talks through good, bad, and exciting in cannabis medicine in this discussion of CBD with Dr. Halpert.  When the Farm Bill expanded access to cannabidiol, manufacturers’ interest exploded.  However, in order to make honest claims, Dr. Halpert teamed with Medterra CBD to determine the real healing powers of this remarkable cannabinoid.  When Dr. Halpert, an expert in the field of immunology and inflammation was hired by Medterra, his professional interests centered around the quality, amount, and dosing of CBD as well as its functionality.  Whether determined by double blind studies, studies in humans, dogs and/or on himself he engages in a frank discussion about his findings with John.  He also confirms Baylor will enter the testing of CBD.Dr. Halpert discusses the federal constraints around cannabis, its Schedule I status and how CBD testing remains erratic and difficult to distinguish.  However, in dog studies, CBD showed remarkable action against osteoarthritis which continued to be effective long after the dosing stopped.While Dr. Halpert has never worked with THC, he agrees that the entourage effects require serious scientific analysis and without the science, he fears this remarkable plant will sit on the shelves as a supplement, with the understanding of its quality and the tragic loss of our knowledge of its medical benefits.

Dr. Matthew Halpert holds a Ph.D from the University of Alabama and holds a faculty position at Baylor College of Medicine in Houston, Texas. Dr. Halpert is the Director of Research &amp; Development at Medterra and is currently responsible for all its product related research and development.  These activities include performing pharmacological studies on CBD’s efficacy, while evaluating the latest peer reviewed publications on CBD. Matthew Halpert and <a href="https://unitedpatientsgroup.com/be_informed_be_well/" rel="nofollow" target="_blank">John Malanca</a> discuss his entry into the CBD market and some interesting observation and study results.  John Malanca talks through good, bad, and exciting in cannabis medicine in this discussion of <a href="https://unitedpatientsgroup.com/certified-products/" rel="nofollow" target="_blank">CBD </a>with Dr. Halpert.  When the Farm Bill expanded access to cannabidiol, manufacturers’ interest exploded.  However, in order to make honest claims, Dr. Halpert teamed with Medterra CBD to determine the real healing powers of this remarkable cannabinoid.   When Dr. Halpert, an expert in the field of immunology and inflammation was hired by Medterra, his professional interests centered around the quality, amount, and dosing of CBD as well as its functionality.  Whether determined by double blind studies, studies in humans, dogs and/or on himself he engages in a frank discussion about his findings with John.  He also confirms Baylor will enter the testing of CBD.Dr. Halpert discusses the federal constraints around cannabis, its Schedule I status and how CBD testing remains erratic and difficult to distinguish.  However, in dog studies, CBD showed remarkable action against osteoarthritis which continued to be effective long after the dosing stopped.While Dr. Halpert has never worked with THC, he agrees that the entourage effects require serious scientific analysis and without the science, he fears this remarkable plant will sit on the shelves as a supplement, with the understanding of its quality and the tragic loss of our knowledge of its medical benefits.

Dr. Matthew Halpert - An inside look at Medterra CBD

Dr. Matthew Halpert, instructor of immunology at Baylor College of Medicine, has spent the past year studying and researching the different ways in which CBD interacts with the body: "It's become very evident that CBD can, in fact, interact with the body in a variety of ways, and exert several different health benefits. It is certainly worth it to study CBD and these other cannabinoids and how they may be very helpful." Because regulating cellular homeostasis is beneficial for controlling cancer growth and tumor development, CBD became a subject of interest for Halpert and his team. Halpert is confident that, eventually, doctors will be prescribing CBD to patients and that CBD will be reimbursable by health insurance plans.

Dr. Matthew Halpert, instructor of immunology at Baylor College of Medicine, has spent the past year studying and researching the different ways in which CBD interacts with the body: "It's become very evident that CBD can, in fact, interact with the body in a variety of ways, and exert several different health benefits. It is certainly worth it to study CBD and these other cannabinoids and how they may be very helpful." Because regulating cellular homeostasis is beneficial for controlling cancer growth and tumor development, CBD became a subject of interest for Halpert and his team. Halpert is confident that, eventually, doctors will be prescribing CBD to patients and that CBD will be reimbursable by health insurance plans.

Ep. 497: Dr. Matthew Halpert